Skilled Doctor with extensive experience in patient care, diagnosis and providing quality medical services. Adept at managing medical teams and resolving complex medical cases with utmost precision. Possesses outstanding organizational and communication skills.
1. Farag, Mohamed MD; Diaz, Yordanka;MD, Patel, Harish;MD Colonic Dieulafoy lesion; as a rare cause of lower gastrointestinal bleeding April 2023 case reports in gastroenterology submitted under review.
2. Shehi, Elona MD; Farag, Mohamed MD; Patel, Harish MD, FACG. S1999 Colonic Ischemia Presenting as a Near Obstructing Colonic Mass. The American Journal of Gastroenterology 117(10S):p e1375, October 2022. | DOI: 10.14309/01.ajg.0000864636.72549.e1
3. Ghazanfar H, Kandhi S, Shin D, Muthumanickam A, Gurjar H, Qureshi ZA, Shaban M, Farag M, Haider A, Budhathoki P, Bhatt T, Ghazanfar A, Jyala A, Patel H. Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. Cureus. 2022 Mar 20;14(3):e23333. doi: 10.7759/cureus.23333. PMID: 35464519; PMCID: PMC9017282.
4. Ricardo AC, Chen J, Toth-Manikowski SM, Meza N, Joo M, Gupta S, Lazarous DG, Leaf DE, Lash JP; STOP-COVID Investigators. Hispanic ethnicity and mortality among critically ill patients with COVID-19. PLoS One. 2022 May 18;17(5):e0268022. doi: 10.1371/journal.pone.0268022. PMID: 35584148; PMCID: PMC9116663
5. Ghazanfar H, Kandhi SD, Nawaz I, Javed N, Abraham MC, Farag M, Mahasamudram J, Patel VB, Altaf F, Patel H. Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article. Cureus. 2021 May 20;13(5):e15141. doi: 10.7759/cureus.15141. PMID: 34164242; PMCID: PMC8214471.
6. Gonzalez, Gabriel, Mohamed E. Farag, Ofer Fass, and Hiroshi Mashimo. "Isolation of Stem-Like Cells from Deep Esophageal Glands." Gastroenterology 152, no. 5 (2017): S350.
7. Fass, Ofer. 2017. Bile Acid-Mediated Transdifferentiation of Stem Cells From the Deep Esophageal Glands. Doctoral dissertation, Harvard Medical School.
8. Gupta S, Wang W, Hayek SS, et al. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. 2021;181(1):41–51. doi:10.1001/jamainternmed.2020.6252
9. Friedman, AN, Guirguis, J, Kapoor, R, Gupta, S, Leaf, DE, Timsina, LR; for the STOP-COVID Investigators. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring). 2021; 29: 1719– 1730.
10. Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, Sosa MA, Renaghan AD, Melamed ML, Wilson FP, Neyra JA, Rashidi A, Boyle SM, Anand S, Christov M, Thomas LF, Edmonston D, Leaf DE; STOP-COVID Investigators. Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021 Feb;77(2):190-203.e1. doi: 10.1053/j.ajkd.2020.09.003. Epub 2020 Sep 19. PMID: 32961244; PMCID: PMC7501875.
11. Molnar MZ, Bhalla A, Azhar A, Tsujita M, Talwar M, Balaraman V, Sodhi A, Kadaria D, Eason JD, Hayek SS, Coca SG, Shaefi S, Neyra JA, Gupta S, Leaf DE, Kovesdy CP; STOP-COVID Investigators. Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States. Am J Transplant. 2020 Nov;20(11):3061-3071. doi: 10.1111/ajt.16280. Epub 2020 Sep 15. PMID: 32844546; PMCID: PMC7460925.
12. Flythe, J. E., Assimon, M. M., Tugman, M. J., Chang, E. H., Gupta, S., Shah, J., ... & Leaf, D. E. (2021). STOP-COVID Investigators: Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis, 77(2), 190.